Personalized treatment of patients with rheumatoid arthritis depending on the T-786С eNOS gene promoter polymorphism and concomitant pathology

Please use this identifier to cite or link to this item: http://dspace.bsmu.edu.ua:8080/xmlui/handle/123456789/26215

Full metadata record

DC Field	Value	Language
dc.contributor.author	Bukach, O.	-
dc.contributor.author	Pronina, A.	-
dc.contributor.author	Dariy, Y.	-
dc.contributor.author	Yarovyk, D.	-
dc.contributor.author	Vachil, P.	-
dc.date.accessioned	2025-02-21T13:01:32Z	-
dc.date.available	2025-02-21T13:01:32Z	-
dc.date.issued	2023	-
dc.identifier.other	DOI: 10.5281/zenodo.8266139	-
dc.identifier.uri	http://dspace.bsmu.edu.ua:8080/xmlui/handle/123456789/26215	-
dc.description.abstract	Purpose: optimization of rheumatoid arthritis treatment depending on the T-786C polymorphism of the eNOS gene promoter and comorbid pathology. Conclusions. Therefore, after the treatment, a decrease in the level of acute-phase indicators of inflammation was observed in all polymorphic variants of the T-786C eNOS gene, but it was the most significant in carriers of the TT genotype.	uk_UA
dc.language.iso	en	uk_UA
dc.publisher	Znanstvena misel journal	uk_UA
dc.subject	rheumatoid arthritis	uk_UA
dc.subject	personalized treatment	uk_UA
dc.subject	eNOS gene promoter T-786C polymorphism	uk_UA
dc.subject	arterial hypertension	uk_UA
dc.subject	type 2 diabetes	uk_UA
dc.subject	abdominal obesity	uk_UA
dc.title	Personalized treatment of patients with rheumatoid arthritis depending on the T-786С eNOS gene promoter polymorphism and concomitant pathology	uk_UA
dc.type	Article	uk_UA
Appears in Collections:	Статті

Files in This Item:

File	Description	Size	Format
Bukach O. et al. Personalized_36-42_2023.pdf		188.77 kB	Adobe PDF	View/Open

DSpace JSPUI